| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $680.9M | +46.6% |
| R&D Expense | $236.1M | +31.1% |
| SG&A Expense | $504.5M | +23.1% |
| Operating Income | -$116.7M | +26.8% |
| Pre-tax Income | -$74.2M | +46.6% |
| Income Tax | $473K | -25.6% |
| Net Income | -$74.7M | +46.5% |
| EPS (Basic) | -$0.72 | +50.7% |
| EPS (Diluted) | -$0.72 | +50.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $306.9M | +107.7% |
| Accounts Receivable | $166.5M | +46.0% |
| Inventory | $26.3M | +125.7% |
| Current Assets | $1.31B | +95.8% |
| Total Assets | $1.37B | +87.7% |
| Current Liabilities | $205.7M | +66.5% |
| Total Liabilities | $218.5M | +59.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.2M | +41.1% |
| Capital Expenditures | $322K | +19.7% |
| Investing Cash Flow | -$335.1M | -417.6% |
| Financing Cash Flow | $567.5M | +3086.5% |
| Free Cash Flow | -$73.5M | +40.9% |
| Stockholders' Equity |
| $1.15B |
| +94.2% |